Venlafaxine News and Research

RSS
Venlafaxine is an antidepressant drug that is being evaluated for the treatment of hot flashes in women who have breast cancer.
Stanford study identifies six depression biotypes for personalized treatment

Stanford study identifies six depression biotypes for personalized treatment

Approximately 1 in 6 patients experience antidepressant withdrawal symptoms, systematic review finds

Approximately 1 in 6 patients experience antidepressant withdrawal symptoms, systematic review finds

Common drugs linked to reduced risk of bleeding stroke from brain aneurysm

Common drugs linked to reduced risk of bleeding stroke from brain aneurysm

New AI tool analyzes medical history to match patients with best antidepressant

New AI tool analyzes medical history to match patients with best antidepressant

SSRIs show promise in easing post-COVID struggles, Dutch study reveals

SSRIs show promise in easing post-COVID struggles, Dutch study reveals

New category of depression identified

New category of depression identified

AAN issues new guideline on oral and topical treatments for painful diabetic neuropathy

AAN issues new guideline on oral and topical treatments for painful diabetic neuropathy

Introducing deuterium makes drugs to have a longer effect

Introducing deuterium makes drugs to have a longer effect

Older people taking anxiety drugs and antidepressants more likely to suffer postoperative delirium

Older people taking anxiety drugs and antidepressants more likely to suffer postoperative delirium

Study provides an overview of neonatal withdrawal signs following late in utero exposure to SSRIs

Study provides an overview of neonatal withdrawal signs following late in utero exposure to SSRIs

Fluoxetine (Prozac) performs strongly in vitro against SARS-CoV-2 (including mutants)

Fluoxetine (Prozac) performs strongly in vitro against SARS-CoV-2 (including mutants)

An overview of withdrawal syndromes following discontinuation of psychotropic drugs

An overview of withdrawal syndromes following discontinuation of psychotropic drugs

Increase in out-of-pocket costs associated with lower adherence to neurologic medications

Increase in out-of-pocket costs associated with lower adherence to neurologic medications

Researchers study the effects of antidepressants to identify the least harmful drugs

Researchers study the effects of antidepressants to identify the least harmful drugs

New study shows link between antidepressant use and gestational diabetes mellitus

New study shows link between antidepressant use and gestational diabetes mellitus

Study sheds new light on long-term treatment with antidepressant drugs

Study sheds new light on long-term treatment with antidepressant drugs

Metabolic Syndrome could make it harder for older adults to respond to antidepressant therapy

Metabolic Syndrome could make it harder for older adults to respond to antidepressant therapy

Antidepressants used for chronic pain relief come with significant side effects

Antidepressants used for chronic pain relief come with significant side effects

Older people treated with electroconvulsive therapy for depression may not get relief from insomnia

Older people treated with electroconvulsive therapy for depression may not get relief from insomnia

Study explores precision psychiatry approaches to improve outcomes for patients with depression

Study explores precision psychiatry approaches to improve outcomes for patients with depression

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.